Raritan, NJ, United States of America

Xuqing Zhang

USPTO Granted Patents = 42 

 

 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 140(Granted Patents)


Location History:

  • Montgomery Township, NJ (US) (2006)
  • Exton, PA (US) (2008 - 2012)
  • Raritan, NJ (US) (2007 - 2016)
  • Audubon, PA (US) (2012 - 2020)
  • Spring House, PA (US) (2013 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
Loading Chart...
42 patents (USPTO):Explore Patents

Title: Xuqing Zhang: A Trailblazer in Innovative Therapeutics

Introduction: Xuqing Zhang, based in Raritan, NJ, is a prolific inventor with an impressive portfolio of 42 patents. His contributions span various pharmaceutical advancements, particularly in the treatment of critical health conditions such as type II diabetes. Zhang's work has significantly impacted the field of drug development, showcasing his extensive knowledge and innovative thinking.

Latest Patents: Among Zhang's latest patents, one focuses on GPR120 agonists for the treatment of type II diabetes. This patent discloses compounds, compositions, and methods that aim to treat disorders influenced by the modulation of the GPR120 receptor. The compounds are specifically represented by Formulas I and II, wherein the specific substitutions of Y, R, G, and Q are outlined. Another significant patent involves pyridin-2-one derivatives aimed at serving as EP3 receptor antagonists. This invention provides pharmaceutical compositions containing these derivatives and their applications in treating conditions like impaired oral glucose tolerance and Metabolic Syndrome.

Career Highlights: Xuqing Zhang has collaborated with well-known pharmaceutical companies, including Janssen Pharmaceutica NV and Ortho-McNeil Pharmaceutical Corporation. His career reflects a dedication to advancing medical science, with a focus on developing innovative treatment solutions.

Collaborations: Throughout his career, Zhang has worked alongside notable colleagues, including Zhihua Sui and Xiaojie Li. These collaborative efforts have contributed significantly to the advancement of therapeutic inventions and the development of novel compounds.

Conclusion: Xuqing Zhang exemplifies the spirit of innovation in the pharmaceutical industry. His extensive patent portfolio and collaborative endeavors have paved the way for groundbreaking treatments, particularly for complex disorders such as type II diabetes. Zhang's work stands as a testament to the potential for scientific research to translate into significant advances in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…